🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hyejin Choi

ORCID: 0000-0002-4884-2747

MedicineImmunology and MicrobiologyEngineeringBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer”.

Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer

Cell Reports(2020)10.1016/j.celrep.2019.12.056

N/A

3.3DataRank · unranked

109 citations

Sharrell B. Lee, Akanksha Verma, Franco Izzo, Geoffrey J. Markowitz, Hyejin Choi +11 more

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3418

N/A

0.723DataRank · unranked

123 citations

Barzin Y. Nabet, Hira Rizvi, Aadel A. Chaudhuri, Daniel K. Wells, Mark Dunphy +30 more

Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer

The Journal of Experimental Medicine(2024)10.1084/jem.20231106

N/A

0DataRank · unranked

24 citations

Katherine Hastings, Jungmin Choi, Isabelle Sirois, Arvind Ravi, Francisco Expósito +14 more